Pal N - Search Results

1

Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.

Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SN. Pal N, et al. Obstet Gynecol. 2018 Jan;131(1):109-116. doi: 10.1097/AOG.0000000000002390. Obstet Gynecol. 2018. PMID: 29215513 Free PMC article.

2

Factors prognostic of survival in advanced-stage uterine serous carcinoma.

Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN. Holman LL, et al. Among authors: pal n. Gynecol Oncol. 2017 Jul;146(1):27-33. doi: 10.1016/j.ygyno.2017.04.018. Epub 2017 Apr 30. Gynecol Oncol. 2017. PMID: 28465008 Free PMC article.

3

Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.

Westin SN, Fellman B, Sun CC, Broaddus RR, Woodall ML, Pal N, Urbauer DL, Ramondetta LM, Schmeler KM, Soliman PT, Fleming ND, Burzawa JK, Nick AM, Milbourne AM, Yuan Y, Lu KH, Bodurka DC, Coleman RL, Yates MS. Westin SN, et al. Among authors: pal n. Am J Obstet Gynecol. 2021 Feb;224(2):191.e1-191.e15. doi: 10.1016/j.ajog.2020.08.032. Epub 2020 Aug 15. Am J Obstet Gynecol. 2021. PMID: 32805208 Free PMC article. Clinical Trial.

4

Overall survival after pelvic exenteration for gynecologic malignancy.

Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT. Westin SN, et al. Among authors: pal n. Gynecol Oncol. 2014 Sep;134(3):546-51. doi: 10.1016/j.ygyno.2014.06.034. Epub 2014 Jul 9. Gynecol Oncol. 2014. PMID: 25014540 Free PMC article.

5

PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.

Westin SN, Ju Z, Broaddus RR, Krakstad C, Li J, Pal N, Lu KH, Coleman RL, Hennessy BT, Klempner SJ, Werner HM, Salvesen HB, Cantley LC, Mills GB, Myers AP. Westin SN, et al. Among authors: pal n. Mol Oncol. 2015 Oct;9(8):1694-703. doi: 10.1016/j.molonc.2015.04.014. Epub 2015 May 16. Mol Oncol. 2015. PMID: 26045339 Free PMC article.

6

Predictors of advanced stage colorectal cancer diagnosis: results of a population-based study.

Campbell RJ, Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Herold A. Campbell RJ, et al. Among authors: pal n. Cancer Detect Prev. 2001;25(5):430-8. Cancer Detect Prev. 2001. PMID: 11718449

7

Clinical and demographic predictors of late-stage cervical cancer.

Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Woodard L. Ferrante JM, et al. Among authors: pal n. Arch Fam Med. 2000 May;9(5):439-45. doi: 10.1001/archfami.9.5.439. Arch Fam Med. 2000. PMID: 10810949

8

Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection.

Roetzheim RG, Pal N, van Durme DJ, Wathington D, Ferrante JM, Gonzalez EC, Krischer JP. Roetzheim RG, et al. Among authors: pal n. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):211-8. doi: 10.1067/mjd.2000.106242. J Am Acad Dermatol. 2000. PMID: 10906640

9

The effects of physician supply on the early detection of colorectal cancer.

Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Ayanian JZ, Krischer JP. Roetzheim RG, et al. Among authors: pal n. J Fam Pract. 1999 Nov;48(11):850-8. J Fam Pract. 1999. PMID: 10907621

10

Demographic predictors of melanoma stage at diagnosis.

Van Durme DJ, Ferrante JM, Pal N, Wathington D, Roetzheim RG, Gonzalez EC. Van Durme DJ, et al. Among authors: pal n. Arch Fam Med. 2000 Jul;9(7):606-11. doi: 10.1001/archfami.9.7.606. Arch Fam Med. 2000. PMID: 10910307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

566 results

Search Page